{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:17:47Z","timestamp":1778678267974,"version":"3.51.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060775","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T17:09:37Z","timestamp":1364490577000},"page":"e60775","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Protein Phosphatase Magnesium-Dependent 1\u03b4 (PPM1D) mRNA Expression Is a Prognosis Marker for Hepatocellular Carcinoma"],"prefix":"10.1371","volume":"8","author":[{"given":"Guang-Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Qi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2010.04.032","article-title":"Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China","volume":"53","author":"L Xu","year":"2010","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"728103","DOI":"10.4061\/2011\/728103","article-title":"Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection","volume":"2011","author":"Y Kishi","year":"2011","journal-title":"Int J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","article-title":"TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer","volume":"26","author":"SP Hussain","year":"2007","journal-title":"Oncogene"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/humu.10176","article-title":"TP53 and liver carcinogenesis","volume":"21","author":"F Staib","year":"2003","journal-title":"Hum Mutat"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mam.2007.09.008","article-title":"Hepatocellular carcinoma: epidemiology and clinical aspects","volume":"29","author":"R Mazzanti","year":"2008","journal-title":"Mol Aspects Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.24208","article-title":"Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma","volume":"53","author":"SO Lim","year":"2011","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10555-008-9127-x","article-title":"The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways","volume":"27","author":"X Lu","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20061563","article-title":"Regulation of ATM\/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase","volume":"203","author":"S Shreeram","year":"2006","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng894","article-title":"Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity","volume":"31","author":"DV Bulavin","year":"2002","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1269\/jrr.11110","article-title":"Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma","volume":"53","author":"WS Koom","year":"2012","journal-title":"J Radiat Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng1317","article-title":"Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway","volume":"36","author":"DV Bulavin","year":"2004","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-007-9470-8","article-title":"Medulloblastomas overexpress the p53-inactivating oncogene WIP1\/PPM1D","volume":"86","author":"RC Castellino","year":"2008","journal-title":"J Neurooncol"},{"key":"ref13","first-page":"1876","article-title":"PPM1D is a potential target for 17q gain in neuroblastoma","volume":"63","author":"F Saito-Ohara","year":"2003","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1349-7006.2007.00395.x","article-title":"Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome","volume":"98","author":"P Loukopoulos","year":"2007","journal-title":"Cancer Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1158\/1078-0432.CCR-08-2403","article-title":"PPM1D is a potential therapeutic target in ovarian clear cell carcinomas","volume":"15","author":"DS Tan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-006-9304-y","article-title":"Overexpression of the wip1 gene abrogates the p38 MAPK\/p53\/Wip1 pathway and silences p16 expression in human breast cancers","volume":"101","author":"E Yu","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-005-9017-7","article-title":"The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours","volume":"95","author":"J Rauta","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1349-7006.2011.01898.x","article-title":"Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival","volume":"102","author":"N Satoh","year":"2011","journal-title":"Cancer Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(08)70004-4","article-title":"Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis","volume":"9","author":"W Weichert","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.22580","article-title":"Molecular mechanisms of hepatocellular carcinoma","volume":"48","author":"RN Aravalli","year":"2008","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","article-title":"Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis","volume":"54","author":"TH Um","year":"2011","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e40363","DOI":"10.1371\/journal.pone.0040363","article-title":"Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis","volume":"7","author":"S Jiang","year":"2012","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/gut.2004.054452","article-title":"Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas","volume":"54","author":"Y Murakami","year":"2005","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/onc.2011.399","article-title":"The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation","volume":"31","author":"AY Ali","year":"2012","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.20279","article-title":"High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations","volume":"112","author":"SY Peng","year":"2004","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dld.2008.11.008","article-title":"A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients","volume":"41","author":"YH Yen","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.sla.0000254368.65878.da","article-title":"Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC\/UICC TNM systems in a cohort of 13,772 patients in Japan","volume":"245","author":"M Minagawa","year":"2007","journal-title":"Ann Surg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-07-5262","article-title":"ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma","volume":"14","author":"SY Lin","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:35:07Z","timestamp":1539995707000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060775"}},"subtitle":[],"editor":[{"given":"Rajeev","family":"Samant","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060775","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}